Trials / Completed
CompletedNCT05518136
Evaluations of Cardiopulmonary Function and Motor Development of Congenital Heart Disease
APP Rehabilitation Management and Evaluations of Cardiopulmonary Function and Motor Development in Infants With Congenital Heart Disease: a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Gejingwa Zhao · Academic / Other
- Sex
- All
- Age
- 4 Months – 8 Months
- Healthy volunteers
- Not accepted
Summary
In this single-center, randomized controlled trial, patients (4-8 months) with CHD were randomly assigned to either a recovery group (home-based rehab exercise periodically) supervised by cellphone APP or to a control group. Left ventricular ejection fractions (LVEF), the rate of increase in heart rate (rHRI), and the rate of recovery heart rate (rHRR) were measured for representing cardiopulmonary capacity. The Alberta test and Neuro-intelligence Scale were used to evaluate their motor developmental outcomes. This study verified the feasibility of this rehab method and indicated that 6-month home-based exercise training can improve cardiopulmonary endurance and motor developmental level in infant CHD patients.
Conditions
- Congenital Heart Disease in Children
- Infant Development
- Infant Conditions
- Motor Neuropathy
- Motor Delay
- Cardiopulmonary
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | exercise-guidance on rehab APP | Training motions included sitting balance, hand support, crawling and squatting training12-14 were scheduled for 1 to 3 months postoperatively, moreover, climbing over obstacles was for 3 to 6 months. |
Timeline
- Start date
- 2021-04-10
- Primary completion
- 2021-12-28
- Completion
- 2022-05-25
- First posted
- 2022-08-26
- Last updated
- 2022-08-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05518136. Inclusion in this directory is not an endorsement.